Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Total Hip Arthroplasty Outcomes
Total Hip Arthroplasty ACS NSQIP Outcomes
January 1, 2021 – December 31, 2021
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total hip arthroplasty ACS NSQIP performance benchmarked against 468 participating sites.
|Total Hip Arthroplasty (468 sites)||N||Observed||Expected|
|30 Day Mortality||290||0.69%||0.37%|
|30 Day Morbidity||290||5.17%||4.74%|
|Deep Vein Thrombosis (DVT) / Pulmonary Embolus||290||2.07%||0.97%|
|Urinary Tract Infection (UTI)||290||1.03%||0.67%|
|Surgical Site Infection (SSI)||290||0.69%||2.09%|
|Return to Operating Room (ROR)||290||1.03%||3.05%|
American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.
ᵃExemplary rating; Identified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model